Treatment
Medication clinical trials
We’re tracking 7,138 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07817056Recruiting
Managing blood sugar side effects from inavolisib
This study looks at how to best manage high blood sugar, a common side effect of the drug inavolisib, in people with a certain type of breast cancer. It aims to help patients stay on their treatment and improve their quality of life.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07816783Recruiting
Comparing two imaging scans to find the cause of unexplained fever
This study compares two types of whole-body imaging scans (FDG-PET/CT and CECT-CAP) to see which is better at finding the cause of a fever that has lasted for several weeks without a clear reason. The results may help doctors choose the best test to pinpoint the source of persistent fevers.
Chandigarh, ChandigarhAges 18 years+ - NCT07810504Recruiting
Laser and solution combo for female hair loss
This study tests a combination of a scalp solution and LED light therapy to treat androgenic alopecia (female pattern hair loss). The goal is to see if the two treatments together can help regrow hair and improve scalp health.
Pasadena, CaliforniaAges 35–55 - NCT07809672Recruiting
Stereotactic body radiation therapy for spinal metastases
This trial tests a precise type of radiation therapy for cancer that has spread to the spine. The goal is to see if this treatment is safe and effective in reducing the tumor while protecting your spinal cord and improving your quality of life.
TianjinAges 18 years+ - NCT07814079Recruiting
Targeted ablation for ventricular tachycardia
This study tests a targeted approach to treat ventricular tachycardia (a fast, abnormal heart rhythm) by finding and destroying the specific scar tissue in the heart that causes it. The goal is to improve the success of the standard ablation procedure.
Valhalla, New YorkAges 18 years+ - NCT07816094RecruitingPhase 4
Comparing two doses of entecavir for hepatitis B cirrhosis
This study tests two daily doses of the medicine entecavir to see which one better controls the hepatitis B virus in people with advanced liver scarring (cirrhosis). It aims to find the most effective dose to improve liver health.
Dhaka, Dhaka DivisionAges 18 years+ - NCT07814885Recruiting
Pregnancy weight management service
This study tests a new service to help pregnant women manage their weight healthily. It might help you have a safer pregnancy.
TaipeiAges 20 years+ - NCT07810088RecruitingPhase 2
Dalpiciclib with hormone therapy and blood pressure drug for advanced breast cancer
This trial is testing a new combination of medicines — a CDK4/6 inhibitor (dalpiciclib) plus hormone therapy and a blood pressure drug (olmesartan) — as a first treatment for advanced hormone-positive breast cancer. The goal is to see if this combination helps slow or shrink the cancer better than standard care.
Wuhan, HubeiAges 18–75 - NCT06205862RecruitingPhase 2
Fecal transplant for preventing colon polyp return
This study tests whether taking capsules of healthy bacteria (fecal microbiota transplant) can help prevent colon polyps from coming back after they have been removed. It might be an option for people who have had an adenoma polyp removed and want to reduce the chance of recurrence.
Guangzhou, GuangdongAges 18–75 - NCT06225752RecruitingPhase 3
Probucol for recent stroke or mini-stroke from narrowed arteries
This study tests whether the drug probucol can help people who recently had a stroke or mini-stroke caused by a narrowed artery in the brain or neck. It aims to reduce the risk of future strokes.
WuhuAges 40 years+ - NCT06500403Recruiting
Non-invasive tools for liver injury after chemotherapy
This study tests non-invasive methods to diagnose a liver condition called PSVD in people who have received platinum chemotherapy. It may help find liver problems early without a biopsy.
Guangzhou, GuangdongAges 18–80 - NCT06086457RecruitingPhase 3
Immunotherapy plus chemo with or without radiation for esophageal cancer
This trial tests whether adding radiation therapy to a standard treatment (immunotherapy plus chemotherapy) can help people with advanced esophageal cancer that has spread to up to two organs. The goal is to see if the combination improves outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07802041Enrolling by invitation
Early induction vs waiting for labor after water breaks
This trial compares inducing labor soon after your water breaks to waiting and seeing if labor starts on its own. It aims to find the safest approach for you and your baby.
IslamabadAges 18–45 - NCT06503107RecruitingPhase 1/Phase 2
Nanobody-based CAR-T cells for multiple myeloma
This trial tests a new type of CAR-T cell therapy that targets a protein called BCMA on your myeloma cells. It is for people with multiple myeloma that has not responded to or has come back after several prior treatments.
Wuhan, HubeiAges 18–75 - NCT06502613Recruiting
Scoliosis and Sleep Cycle in Children
This study looks at how sleep timing (melatonin levels) might be linked to new cases of scoliosis in children. If you have scoliosis and are between 6 and 15, you may help researchers understand this connection.
Wenzhou, ZhejiangAges 6–15 - NCT07802431Recruiting
Body contouring treatment for belly and love handles
This trial tests a new non-invasive device to reduce fat in the belly and sides (love handles). It may help people who have stubborn fat in these areas despite a stable weight.
Nuevo León, MonterreyAges 18–65 - NCT07805655Recruiting
Radiofrequency vs. topical therapy for facial acne
This study compares a radiofrequency treatment to a topical cream for facial acne. It aims to see which is more effective for mild to moderate acne in adults.
Nuevo León, MonterreyAges 18–40 - NCT06022653Recruiting
Aorta and peripheral artery disease registry
This study collects information from people who have had treatment for aorta or peripheral artery disease at Asan Medical Center since 2011. It helps researchers understand how patients are doing over time.
SeoulAges 19 years+ - NCT06354140RecruitingPhase 2
Tislelizumab plus S-1 for esophageal cancer after surgery
This trial tests a combination of the immunotherapy drug tislelizumab and the chemotherapy drug S-1 for people with a specific type of esophageal cancer that still has some cancer cells in the main tumor but no cancer in lymph nodes after surgery. The goal is to see if this treatment can help prevent the cancer from coming back.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT06506292RecruitingPhase 2
Study of adebrelimab plus chemo before and after stomach cancer surgery
This trial tests combining adebrelimab (an immunotherapy) with chemotherapy (XELOX) before and after surgery for stomach cancer that hasn't spread. The goal is to see if this approach helps shrink tumors and improves outcomes.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06505369RecruitingPhase 2
Immune therapy for newly diagnosed multiple myeloma before stem cell transplant
This trial tests a type of immune therapy called bispecific T-cell redirectors combined with standard medicines for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The goal is to see if this treatment helps control the cancer better.
CopenhagenAges 18–70 - NCT07801638Recruiting
Anticoagulation plus tocilizumab for cerebral venous thrombosis
This trial tests a combination of blood thinners (anticoagulation) and a drug called tocilizumab, which targets inflammation, to treat acute cerebral venous thrombosis (a blood clot in a vein in the brain). It aims to see if this combined treatment improves recovery and reduces complications compared to blood thinners alone.
Beijing, Beijing MunicipalityAges 18–80 - NCT07801001Enrolling by invitation
Zinc supplements for women with polycystic ovary syndrome
This study tests whether taking zinc supplements can improve insulin resistance and reduce symptoms in women with polycystic ovary syndrome (PCOS). If you have PCOS and are not pregnant, you may be able to join.
DhakaAges 18–45 - NCT07806994Recruiting
Eye tracking and hand use in children with cerebral palsy
This study uses eye-tracking technology to see how children with cerebral palsy use their eyes and hands together during tasks that involve both hands. It may help improve understanding of motor control and guide future therapies.
Seoul, SeoulAges 6–12
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,138 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.